Compass Therapeutics, Inc. (CMPX) NASDAQ
5.19
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.19
+0(+0.00%)
Currency In USD
| Market Cap | 846.82M |
| Enterprise Value | 826.01M |
| P/E Ratio | -14.43 |
| PEG Ratio | -3.39 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.87 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -13.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.3 |
| Return On Equity | -0.44 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -72.84M |
| Net Income | -66.49M |
| Diluted EPS | -0.42 |
| Total Cash | 208.91M |
| Total Cash/Share | 1.13 |
| Total Debt | 9.83M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 15.02 |
| Book Value Per Share | 1.06 |
| 52-Week Change | 110.98 |
| 52-Week High | 6.88 |
| 52-Week Low | 1.33 |
| Moving Average 50 Days | 5.88 |
| Moving Average 200 Days | 4.19 |
| Average Volume | 2.22M |
| Shares Outstanding | 138.29M |
| % Held by Institutions | 118.67 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |